You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

 

Online download statistics by month:

Online download statistics by month: June 2020 to April 2026

AbstractFullPdf
Jun 202016016056
Jul 202014914952
Aug 2020989634
Sep 202010910975
Oct 202014014051
Nov 202012112048
Dec 202014114136
Jan 202116116154
Feb 202115515548
Mar 202125125188
Apr 202122722744
May 202118718750
Jun 202117417485
Jul 202113313338
Aug 202111311441
Sep 202116216257
Oct 202112812976
Nov 202113513551
Dec 202114614751
Jan 202214314635
Feb 202210010445
Mar 2022909832
Apr 202212413242
May 202215615969
Jun 202213013353
Jul 202212514050
Aug 202212212853
Sep 202210110467
Oct 20229610336
Nov 202214314847
Dec 2022919221
Jan 2023878931
Feb 202311711841
Mar 202311211545
Apr 2023535734
May 2023515221
Jun 2023656627
Jul 2023646834
Aug 2023859039
Sep 2023646422
Oct 202315515632
Nov 202322922929
Dec 2023767723
Jan 2024484927
Feb 2024727442
Mar 2024919247
Apr 2024858846
May 2024868827
Jun 202410210139
Jul 2024737535
Aug 2024494928
Sep 2024777941
Oct 202411611847
Nov 2024929426
Dec 202416217051
Jan 202510610738
Feb 2025929438
Mar 20259910151
Apr 202512212231
May 2025687033
Jun 2025434313
Jul 2025110
Sep 2025110
Apr 2026110
Total705571752623